Mycobacterium haemophilum Infection after Alemtuzumab Treatment

被引：18

作者：

Kamboj, Mini ^{[1
]}

Louie, Eddie ^{[2
]}

Keihn, Timothy

Papanicolaou, Genovefa

Glickman, Michael

Sepkowitz, Kent

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA

[2] NYU, New York, NY USA

来源：

EMERGING INFECTIOUS DISEASES | 2008年 / 14卷 / 11期

关键词：

D O I：

10.3201/eid1411.071321

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1821 / 1823

页数：3

共 10 条

[1] Tuberculosis due to Mycobacterium bovis after alemtuzumab administration [J].

Abad, S ;

Gyan, E ;

Moachon, L ;

Bouscary, D ;

Sicard, D ;

Dreyfus, F ;

Blanche, P .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) :E27-E28

[2]

Ferrajoli A, 2001, EXPERT OPIN BIOL TH, V1, P1059

[3] Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning [J].

Ho, AYL ;

Pagliuca, A ;

Kenyon, M ;

Parker, JE ;

Mijovic, A ;

Devereux, S ;

Mufti, GJ .

BLOOD, 2004, 104 (06) :1616-1623

[4] Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study [J].

Keating, MJ ;

Flinn, I ;

Jain, V ;

Binet, JL ;

Hillmen, P ;

Byrd, J ;

Albitar, M ;

Brettman, L ;

Santabarbara, P ;

Wacker, B ;

Rai, KR .

BLOOD, 2002, 99 (10) :3554-3561

[5] Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody [J].

Peleg, Anton Y. ;

Husain, Shahid ;

Kwak, Eun J. ;

Silveira, Fernanda P. ;

Ndirangu, Magdaline ;

Tran, Jerry ;

Shutt, Kathleen A. ;

Shapiro, Ron ;

Thai, Ngoc ;

Abu-Elmagd, Kareem ;

McCurry, Kenneth R. ;

Marcos, Amadeo ;

Paterson, David L. .

CLINICAL INFECTIOUS DISEASES, 2007, 44 (02) :204-212

[6] Mycobacterium haemophilum: Microbiology and expanding clinical and geographic spectra of disease in humans [J].

Saubolle, MA ;

Kiehn, TE ;

White, MH ;

Rudinsky, MF ;

Armstrong, D .

CLINICAL MICROBIOLOGY REVIEWS, 1996, 9 (04) :435-&

[7] Mycobacterium haemophilum in immunocompromised patients [J].

Shah, MK ;

Sebti, A ;

Kiehn, TE ;

Massarella, SA ;

Sepkowitz, KA .

CLINICAL INFECTIOUS DISEASES, 2001, 33 (03) :330-337

[8] Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation [J].

Shapiro, Ron ;

Ellis, Demetrius ;

Tan, Henkie P. ;

Moritz, Michael L. ;

Basu, Amit ;

Vats, Abhay N. ;

Khan, Akhtar S. ;

Gray, Edward A. ;

Zeevi, Adrianna ;

McFeaters, Corde ;

James, Gerri ;

Grosso, Mary Jo ;

Marcos, Amadeo ;

Starzl, Thomas E. .

JOURNAL OF PEDIATRICS, 2006, 148 (06) :813-818

[9] MYCOBACTERIUM-HAEMOPHILUM SP-NOV, A NEW PATHOGEN OF HUMANS [J].

SOMPOLINSKY, D ;

LAGZIEL, A ;

NAVEH, D ;

YANKILEVITZ, T .

INTERNATIONAL JOURNAL OF SYSTEMATIC BACTERIOLOGY, 1978, 28 (01) :67-75

[10] Mycobacterium haemophilum and lymphadenitis in children [J].

van Coppenraet, LES ;

Kuijper, EJ ;

Lindeboom, JA ;

Prins, JM ;

Claas, ECJ .

EMERGING INFECTIOUS DISEASES, 2005, 11 (01) :62-68

← 1 →